16-20032530-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001002911.4(GPR139):c.267T>A(p.Asp89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001002911.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR139 | NM_001002911.4 | c.267T>A | p.Asp89Glu | missense_variant | 2/2 | ENST00000570682.2 | NP_001002911.1 | |
GPR139 | NM_001318483.1 | c.-13T>A | 5_prime_UTR_variant | 3/3 | NP_001305412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR139 | ENST00000570682.2 | c.267T>A | p.Asp89Glu | missense_variant | 2/2 | 1 | NM_001002911.4 | ENSP00000458791.2 | ||
GPR139 | ENST00000326571.7 | n.*213T>A | non_coding_transcript_exon_variant | 3/3 | 1 | ENSP00000370779.5 | ||||
GPR139 | ENST00000326571.7 | n.*213T>A | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000370779.5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 251146Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135702
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461878Hom.: 0 Cov.: 33 AF XY: 0.0000523 AC XY: 38AN XY: 727238
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.267T>A (p.D89E) alteration is located in exon 2 (coding exon 2) of the GPR139 gene. This alteration results from a T to A substitution at nucleotide position 267, causing the aspartic acid (D) at amino acid position 89 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at